InnoRa

Executive Summary

InnoRa is a Berlin-based private company founded in 2001 that specializes in drug-coated balloon catheters for vascular interventions. The company’s technology enables targeted drug delivery to arterial walls during angioplasty, reducing restenosis rates and offering new therapeutic options in peripheral and coronary artery disease. By developing sophisticated, customer-specific products, InnoRa partners with medical device firms to bring customized solutions to market, leveraging their expertise in coating technologies and interventional cardiology. Despite a niche focus, the company's long history in the space suggests a strong technical foundation and established manufacturing capabilities. With no disclosed funding rounds or revenue data, InnoRa appears to operate as a stealth or privately funded contract development and manufacturing organization (CDMO) rather than a drug developer seeking public listing.

Upcoming Catalysts (preview)

• Q3 2026FDA or CE Mark approval for next-generation drug-coated balloon40% success
• TBDNew strategic partnership with a major vascular device company60% success
• Q1 2027Clinical data readout from ongoing trial for a novel indication (e.g., AV fistula)35% success